138 related articles for article (PubMed ID: 7512575)
1. Interleukin-6 secretion from human astrocytoma cells induced by substance P.
Gitter BD; Regoli D; Howbert JJ; Glasebrook AL; Waters DC
J Neuroimmunol; 1994 Apr; 51(1):101-8. PubMed ID: 7512575
[TBL] [Abstract][Full Text] [Related]
2. Different susceptibility to neurokinin 1 receptor antagonists of substance P and septide-induced interleukin-6 release from U373 MG human astrocytoma cell line.
Palma C; Goso C; Manzini S
Neurosci Lett; 1994 Apr; 171(1-2):221-4. PubMed ID: 7521949
[TBL] [Abstract][Full Text] [Related]
3. Substance P induces secretion of immunomodulatory cytokines by human astrocytoma cells.
Palma C; Manzini S
J Neuroimmunol; 1998 Jan; 81(1-2):127-37. PubMed ID: 9521614
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 production by U373 MG, a human astrocytoma cell line: different pathways involved in substance P and lipopolysaccharide activation.
Palma C; Urbani F; Manzini S
J Neuroimmunol; 1995 Jun; 59(1-2):155-63. PubMed ID: 7541052
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of substance P receptors on cultured human spinal cord astrocytes: synergism of substance P with cytokines in inducing interleukin-6 and prostaglandin E2 production.
Palma C; Minghetti L; Astolfi M; Ambrosini E; Silberstein FC; Manzini S; Levi G; Aloisi F
Glia; 1997 Oct; 21(2):183-93. PubMed ID: 9336233
[TBL] [Abstract][Full Text] [Related]
6. Ketamine suppresses the substance P-induced production of IL-6 and IL-8 by human U373MG glioblastoma/astrocytoma cells.
Yamaguchi K; Kumakura S; Murakami T; Someya A; Inada E; Nagaoka I
Int J Mol Med; 2017 Mar; 39(3):687-692. PubMed ID: 28204809
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.
Gitter BD; Bruns RF; Howbert JJ; Waters DC; Threlkeld PG; Cox LM; Nixon JA; Lobb KL; Mason NR; Stengel PW
J Pharmacol Exp Ther; 1995 Nov; 275(2):737-44. PubMed ID: 7473161
[TBL] [Abstract][Full Text] [Related]
8. Substance P enhances the secretion of tumor necrosis factor-alpha from neuroglial cells stimulated with lipopolysaccharide.
Luber-Narod J; Kage R; Leeman SE
J Immunol; 1994 Jan; 152(2):819-24. PubMed ID: 7506735
[TBL] [Abstract][Full Text] [Related]
9. Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists.
Derocq JM; Ségui M; Blazy C; Emonds-Alt X; Le Fur G; Brelire JC; Casellas P
FEBS Lett; 1996 Dec; 399(3):321-5. PubMed ID: 8985172
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the release of interleukin-6 from human astrocytoma cells.
Cadman ED; Witte DG; Lee CM
J Neurochem; 1994 Sep; 63(3):980-7. PubMed ID: 7519668
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.
Guo CJ; Douglas SD; Gao Z; Wolf BA; Grinspan J; Lai JP; Riedel E; Ho WZ
Glia; 2004 Nov; 48(3):259-66. PubMed ID: 15390113
[TBL] [Abstract][Full Text] [Related]
12. Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells.
Gitter BD; Cox LM; Rydel RE; May PC
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10738-41. PubMed ID: 7479875
[TBL] [Abstract][Full Text] [Related]
13. Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway.
Luo W; Sharif TR; Sharif M
Cancer Res; 1996 Nov; 56(21):4983-91. PubMed ID: 8895754
[TBL] [Abstract][Full Text] [Related]
14. Tachykinin receptors in the small intestine of the cane toad (Bufo marinus): a radioligand binding and functional study.
Burcher E; Warner FJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):692-700. PubMed ID: 9686947
[TBL] [Abstract][Full Text] [Related]
15. Yokukansan, a Japanese Herbal Medicine, Suppresses Substance PInduced Production of Interleukin-6 and Interleukin-8 by Human U373 MG Glioblastoma Astrocytoma Cells.
Yamaguchi K; Yamazaki S; Kumakura S; Someya A; Iseki M; Inada E; Nagaoka I
Endocr Metab Immune Disord Drug Targets; 2020; 20(7):1073-1080. PubMed ID: 32003704
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide enhances substance P-mediated neutrophil adherence to epithelial cells and cytokine release.
Kuo HP; Lin HC; Hwang KH; Wang CH; Lu LC
Am J Respir Crit Care Med; 2000 Nov; 162(5):1891-7. PubMed ID: 11069831
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic distribution of brain neurokinin-1/substance P receptors using a highly selective ligand [3H]-[Sar9,Met(O2)11]-substance P.
Dam TV; Martinelli B; Quirion R
Brain Res; 1990 Oct; 531(1-2):333-7. PubMed ID: 1705154
[TBL] [Abstract][Full Text] [Related]
18. Human astrocytoma cells (U-87 MG) exhibit a specific substance P binding site with the characteristics of an NK-1 receptor.
Ogo H; Kuroyanagi N; Inoue A; Nishio H; Hirai Y; Akiyama M; DiMaggio DA; Krause JE; Nakata Y
J Neurochem; 1996 Nov; 67(5):1813-20. PubMed ID: 8863485
[TBL] [Abstract][Full Text] [Related]
19. SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.
Taracanova A; Alevizos M; Karagkouni A; Weng Z; Norwitz E; Conti P; Leeman SE; Theoharides TC
Proc Natl Acad Sci U S A; 2017 May; 114(20):E4002-E4009. PubMed ID: 28461492
[TBL] [Abstract][Full Text] [Related]
20. Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and nuclear factor-IL-6.
Lieb K; Schaller H; Bauer J; Berger M; Schulze-Osthoff K; Fiebich BL
J Neurochem; 1998 Apr; 70(4):1577-83. PubMed ID: 9523575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
